Serial measurement of growth-differentiation factor-15 in heart failure: relation to disease severity and prognosis in the Valsartan Heart Failure Trial.

Anand, Inder S; Kempf, Tibor; Rector, Thomas S; Tapken, Heike; Allhoff, Tim; Jantzen, Franziska; Kuskowski, Michael; Cohn, Jay N; Drexler, Helmut; Wollert, Kai C

Anand, Inder S; Kempf, Tibor; Rector, Thomas S; Tapken, Heike; Allhoff, Tim; Jantzen, Franziska; Kuskowski, Michael; Cohn, Jay N; Drexler, Helmut; Wollert, Kai C.

Affiliation

Anand IS; Cardiology 111-C, VA Medical Center, 1 Veterans Drive, Minneapolis, MN 55417, USA. anand001@umn.edu

Circulation ; 122(14): 1387-95, 2010 Oct 05.

Article in En | MEDLINE | ID: mdl-20855664

Subject(s)

Growth Differentiation Factor 15/blood; Heart Failure/physiopathology; Tetrazoles/therapeutic use; Valine/analogs & derivatives; Aged; Angiotensin II Type 1 Receptor Blockers/therapeutic use; Atrial Fibrillation/complications; Biomarkers/blood; Diabetic Angiopathies/epidemiology; Female; Heart Failure/blood; Heart Failure/drug therapy; Heart Failure/mortality; Humans; Hypertension/complications; Male; Middle Aged; Placebos; Prognosis; Regression Analysis; Risk Assessment; Risk Factors; Severity of Illness Index; Valine/therapeutic use; Valsartan

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Tetrazoles / Valine / Growth Differentiation Factor 15 / Heart Failure Type of study: Clinical_trials / Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Circulation Year: 2010 Type: Article Affiliation country: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google